Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
delolimogene mupadenorepvec
atezolizumab
Locations
3
United States
Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute
Los Angeles, California, United States
Baylor St Luke's Medical Center
Houston, Texas, United States
Uppsala University Hospital
Uppsala, Sweden
Start Date
January 28, 2020
Primary Completion Date
July 30, 2023
Completion Date
July 30, 2023
Last Updated
September 19, 2024
NCT07371663
NCT06794775
NCT01898039
NCT06209580
NCT05478876
NCT04879654
Lead Sponsor
Lokon Pharma AB
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions